The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent
Open accessAbstract
Like acetylcholinesterase, butyrylcholinesterase (BChE) inactivates the neurotransmitter acetylcholine (ACh) and is hence a viable therapeutic target in Alzheimer's disease, which is characterized by a cholinergic deficit. Potent, reversible, and brain-targeted BChE inhibitors (cymserine analogs) were developed based on binding domain structures to help elucidate the role of this enzyme in the central nervous system. In rats, cymserine analogs caused long-term inhibition of brain BChE and elevated extracellular ACh levels, without inhibitory effects on acetylcholinesterase. In rat brain slices, selective BChE inhibition augmented long-term potentiation. These compounds also improved the cognitive performance (maze navigation) of aged rats. In cultured human SK-N-SH neuroblastoma cells, intra- and extracellular β-amyloid precursor protein, and secreted β-amyloid peptide levels were reduced without affecting cell viability. Treatment of transgenic mice that overexpressed human mutant amyloid precursor protein also resulted in lower β-amyloid peptide brain levels than controls. Selective, reversible inhibition of brain BChE may represent a treatment for Alzheimer's disease, improving cognition and modulating neuropathological markers of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
A new and rapid colorimetric determination of acetylcholinesterase activity
Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,126
The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 8,209
Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471
Acetylcholinesterase — new roles for an old actor
Soreq, H., & Seidman, S. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067589 · Cited by 1,390
Borchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., Copeland, N. G., Price, D. L., & Sisodia, S. S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80974-5 · Cited by 1,023
The biology of cholinesterases
Silver, A. (1974) · Medical Entomology and Zoology · Cited by 891
Neurobiology of butyrylcholinesterase
Darvesh, S., Hopkins, D. A., & Geula, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1035 · Cited by 891
Turner, P. R., O’Connor, K., Tate, W. P., & Abraham, W. C. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00089-3 · Cited by 756
The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease
Westerman, M. A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L. H., Carlson, G. A., Younkin, S. G., & Ashe, K. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01858.2002 · Cited by 718
Mesulam, M.-M., Guillozet, A., Shaw, P., Levey, A., Duysen, E. G., & Lockridge, O. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00613-3 · Cited by 650
CHANGES IN BRAIN CHOLINESTERASES IN SENILE DEMENTIA OF ALZHEIMER TYPE
PERRY, E. K., PERRY, R. H., BLESSED, G., & TOMLINSON, B. E. (1978) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1978.tb00545.x · Cited by 555
Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice
Anagnostaras, S. G., Murphy, G. G., Hamilton, S. E., Mitchell, S. L., Rahnama, N. P., Nathanson, N. M., & Silva, A. J. (2003) · Nature Neuroscience · doi:10.1038/nn992 · Cited by 544
Amyloid-β oligomers: their production, toxicity and therapeutic inhibition
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Rowan, M. J., & Selkoe, D. J. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300552 · Cited by 507
Timing and Location of Nicotinic Activity Enhances or Depresses Hippocampal Synaptic Plasticity
Ji, D., Lape, R., & Dani, J. A. (2001) · Neuron · doi:10.1016/s0896-6273(01)00332-4 · Cited by 419
Li, B., Stribley, J. A., Ticu, A., Xie, W., Schopfer, L. M., Hammond, P., Brimijoin, S., Hinrichs, S. H., & Lockridge, O. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.751320.x · Cited by 354
Cholinesterases: Roles in the Brain During Health and Disease
Ballard, C., Greig, N., Guillozet-Bongaarts, A., Enz, A., & Darvesh, S. (2005) · Current Alzheimer Research · doi:10.2174/1567205054367838 · Cited by 350
Self-citationStable hippocampal long-term potentiation elicited by ‘theta’ pattern stimulation
Staubli, U., & Lynch, G. (1987) · Brain Research · doi:10.1016/0006-8993(87)91605-2 · Cited by 345
Endocannabinoids facilitate the induction of LTP in the hippocampus
Carlson, G., Wang, Y., & Alger, B. E. (2002) · Nature Neuroscience · doi:10.1038/nn879 · Cited by 335
Self-citationArendt, T., Brückner, M. K., Lange, M., & Bigl, V. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90189-x · Cited by 314
Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain
Mesulam, M., Guillozet, A., Shaw, P., & Quinn, B. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0462 · Cited by 314
Butyrylcholinesterase in the life cycle of amyloid plaques
Guillozet, A. L., Mesulam, M. ‐., Smiley, J. F., & Mash, D. C. (1997) · Annals of Neurology · doi:10.1002/ana.410420613 · Cited by 310
Cholinergic function and Alzheimer's disease
Giacobini, E. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.935 · Cited by 283
Glutamatergic systems in Alzheimer's disease
Francis, P. T. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.934 · Cited by 242
Giacobini, E., Spiegel, R., Enz, A., Veroff, A. E., & Cutler, N. R. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200089 · Cited by 222
Yu, Q.-S., Holloway, H. W., Utsuki, T., Brossi, A., & Greig, N. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980459s · Cited by 210
Self-citationShaw, K. T. Y., Utsuki, T., Rogers, J., Yu, Q.-S., Sambamurti, K., Brossi, A., Ge, Y.-W., Lahiri, D. K., & Greig, N. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131152998 · Cited by 205
Self-citationSynaptic plasticity in animal models of early Alzheimer's disease
Rowan, M. J., Klyubin, I., Cullen, W. K., & Anwyl, R. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2002.1240 · Cited by 203
Cholinesterases and the Pathology of Alzheimer Disease
Geula, C., & Mesulam, M. M. (1995) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199501002-00005 · Cited by 193
Shaji, K. S., Smitha, K., Lal, K. P., & Prince, M. J. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.649 · Cited by 191
Lahiri, D., Farlow, M., Sambamurti, K., Greig, N., Giacobini, E., & Schneider, L. (2003) · Current Drug Targets · doi:10.2174/1389450033346957 · Cited by 185
Self-citationAdvances in the Cellular and Molecular Biology of the Beta-Amyloid Protein in Alzheimer 's Disease
Sambamurti, K., Greig, N. H., & Lahiri, D. K. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:1:1:1 · Cited by 185
Self-citationDistribution of butyrylcholinesterase in the human amygdala and hippocampal formation
Darvesh, S., Grantham, D. L., & Hopkins, D. A. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980413)393:3<374::aid-cne8>3.0.co;2-z · Cited by 164
Pseudocholinesterase staining in the primary visual pathway of the macaque monkey
Graybiel, A. M., & Ragsdale, C. W. (1982) · Nature · doi:10.1038/299439a0 · Cited by 115
Human Cholinesterases and Anticholinesterases
(1993) · Elsevier eBooks · doi:10.1016/b978-0-12-655290-4.x5001-4 · Cited by 110
Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats
Scali, C., Giovannini, M. G., Bartolini, L., Prosperi, C., Hinz, V. C., Schmidt, B. H., & Pepeu, G. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00128-3 · Cited by 99
Self-citationHolmes, C. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.039321 · Cited by 97
Regulation of attention and response to therapy in dementia by butyrylcholinesterase
O’Brien, K. K., Saxby, B. K., Ballard, C. G., Grace, J., Harrington, F., Ford, G. A., O'Brien, J. T., Swan, A., FAIRBAIRN, A. F., Wesnes, K. A., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200304000-00008 · Cited by 90
Cholinesterase inhibitors, β-amyloid precursor protein and amyloid β-peptides in Alzheimer's disease
Lahiri, D. K., Farlow, M. R., Hintz, N., Utsuki, T., & Greig, N. H. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.00309.x · Cited by 82
Self-citationThe experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics
Greig, N. H., Micheli, E. D., Holloway, H. W., Yu, Q.-S., Utsuki, T., Perry, T., Ingram, D. K., Deutsch, J., Lahiri, D. K., & Soncrant, T. T. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.00311.x · Cited by 70
Self-citationButyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodies
Perry, E., McKeith, I., & Ballard, C. (2003) · Neurology · doi:10.1212/01.wnl.0000068336.84399.9e · Cited by 70
Scali, C., Giovannini, M. G., Prosperi, C., Bartolini, L., & Pepeu, G. (1997) · Pharmacological Research · doi:10.1006/phrs.1997.0252 · Cited by 58
Self-citationDementia: The neurochemical basis of putative transmitter orientated therapy
COURT, J. A., & Perry, E. K. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90035-k · Cited by 51
Maze learning in aged rats is enhanced by phenserine, a novel anticholinesterase
Ikari, H., Spangler, E. L., Greig, N. H., Pei, X., Brossi, A. R., Speer, D. L., Patel, N., & Ingram, D. K. (1995) · Neuroreport · doi:10.1097/00001756-199502000-00019 · Cited by 44
Self-citationWang, Y., Wu, J., Rowan, M. J., & Anwyl, R. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.467bb.x · Cited by 43
Self-citationCholinergic plasticity in the hippocampus
Colgin, L. L., Kubota, D., & LYNCH, G. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530289100 · Cited by 42
Stefanova, E. D., Blennow, K., Almkvist, O., Hellström‐Lindahl, E., & Nordberg, A. K. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01384-8 · Cited by 40
Ingram, D. K., Shimada, A., Spangler, E. L., Ikari, H., Hengemihle, J. M., Kuo, H., & Greig, N. H. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb39076.x · Cited by 40
Self-citationAlteration of cardiovascular and neuronal function in M1 knockout mice
Hamilton, S. E., Hardouin, S. N., Anagnostaras, S., Murphy, G. G., Richmond, K. N., Silva, A. J., Feigl, E. O., & Nathanson, N. M. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01043-8 · Cited by 34
Membranous lipodystrophy presenting with palilalia: a PET study of cerebral glucose metabolism
Ueki, Y., Kohara, N., Oga, T., Fukuyama, H., AKIGUCHI, I., Kimura, J., & Shibasaki, H. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.102001060.x · Cited by 20
Wheal, H. V., Lancaster, B., & Bliss, T. V. P. (1983) · Brain Research · doi:10.1016/0006-8993(83)90570-x · Cited by 16
Cited by
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Manczak, M., Calkins, M. J., & Reddy, P. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr139 · Cited by 827
Calkins, M. J., Manczak, M., Mao, P., Shirendeb, U., & Reddy, P. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr381 · Cited by 646
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
Schliebs, R., & Arendt, T. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0579-2 · Cited by 530
Metadata
- Authors
- Greig, N. H., Utsuki, T., Ingram, D. K., Wang, Y., Pepeu, G., Scali, C., Yu, Q.-S., Mamczarz, J., Holloway, H. W., Giordano, T., Chen, D., Furukawa, K., Sambamurti, K., Brossi, A., & Lahiri, D. K.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-11-07
- Volume
- 102
- Issue
- 47
- Pages
- 17213-17218
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2159866533
- Cited by
- 734
- References
- 51
- FWCI
- 11.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.